Latest blog articles

  • Legal reforms for economic development in Africa: how effective?

    This PhD thesis by Ify Ogo evaluates the effectiveness of the public finance legislations in Nigeria and Rwanda, through the observation and analysis of the effect of law on the behaviour of public institutions between 2005 and 2015, and the impact on public debt portfolios, which continue to...

    Abuja_federal_capital_territory
  • Renewable energy technology - fair and equitable treatment standard?

    Although decreasing costs of renewable energy technology have made renewable energy projects more commercially viable, investment in renewables remains highly capital-intensive, due to large necessary upfront costs, and is not considered profitable in the short-term.

    Renewable energy_law Blogs Maastricht
  • Louboutin red sole shoes and copycats

    Christian Louboutin vs Van Haren Schoenen - The CJEU is to decide as to whether or not the red colour on soles of Louboutin shoes represents an aspect of a shape of the product, in which case it would not be protectable.

    Louboutin_heels
  • Is health care a human right?

    Trevor Burrus claims that health care cannot be a fundamental right. He is not alone in saying this, but the way he says it is noteworthy. His article is not original (nor does it claim to be), but it represents an admirably clear retelling of an old story: Positive rights cannot be rights, this is...

    lawblog.maastrichtuniversity.nl
  • The future of the EU’s fiscal framework

    Recent events suggest that the Eurozone may soon be entering a new phase of its short but already tumultuous life. As the dust of the sovereign debt crisis starts settling, and the continent slowly returns to growth, winds of change are blowing across the zone, and EMU reform is back on the EU...

    lawblog.maastrichtuniversity.nl
  • Compulsory licensing for pharmaceuticals in investor-state arbitration

    A patent for a medicine gives the patent owner an exclusive right to prevent others from commercially exploiting the patented medicine. When patent regimes work well, the patent holder receives a return for costs of research and development enabling him to continue making further investments.  

    Pharma patent